Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01056133
What this trial is testing

Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNon-alcoholic Steatohepatitis
Johane Allard 20
Not applicableNot Yet RecruitingNCT06537466
What this trial is testing

Ketogenic Diet in MASLD-related cACLD

Who this might be right for
Steatohepatitis, NonalcoholicSteatosis of LiverCirrhosis, Liver
University of Palermo 50
Not applicableUnknownNCT02174367
What this trial is testing

An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis

Who this might be right for
Psoriasis ChronicLiver FibrosisFatty Liver+1 more
King's College London 400
Testing effectiveness (Phase 2)Study completedNCT03763877
What this trial is testing

The Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD

Who this might be right for
Nonalcoholic Fatty Liver
Poxel SA 121
Not applicableUnknownNCT06101758
What this trial is testing

Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER Study

Who this might be right for
Liver CirrhosisNon-Alcoholic Fatty Liver DiseaseHepatocellular Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 125
Large-scale testing (Phase 3)Ended earlyNCT00577148
What this trial is testing

An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes

Who this might be right for
Fatty Liver
Sanofi 89
Testing effectiveness (Phase 2)Active Not RecruitingNCT05573204
What this trial is testing

Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients with Non-alcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis
Tanta University 59
Testing effectiveness (Phase 2)WithdrawnNCT04216693
What this trial is testing

Digoxin for Patients With Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicableEnrolling By InvitationNCT04066608
What this trial is testing

Prevalence of Advanced Fibrosis in Patients Living With HIV

Who this might be right for
Fatty Liver Disease
Johannes Gutenberg University Mainz 300
Not applicableActive Not RecruitingNCT06950710
What this trial is testing

Mechanisms of Macrophage Polarization in HIRI in Patients With NAFLD

Who this might be right for
Hepatic Ischemia-reperfusion InjuryNon-alcoholic Fatty Liver Disease
Zhifeng Gao 300
Not applicableUnknownNCT06495333
What this trial is testing

Fecal Microbiota Analysis of PNPLA3 Polymorphism in Hispanic Patients With MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
Fundacion de Investigacion Science and Education 100
Not applicableStudy completedNCT07663682
What this trial is testing

Correlation Between Serum Nociceptin and Sympathetic Nerve Activity in Diabetic Patients With MAFLD

Who this might be right for
Diabetes Mellitus, Type 2Metabolic Associated Fatty Liver Disease
Second Hospital of Shanxi Medical University 100
Not applicableStudy completedNCT05497765
What this trial is testing

An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Guangzhou Medical University 94
Testing effectiveness (Phase 2)Ended earlyNCT02913105
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH

Who this might be right for
Non-alcoholic Steatohepatitis NASH
Novartis Pharmaceuticals 122
Not applicableNot Yet RecruitingNCT06546384
What this trial is testing

GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease

Who this might be right for
AdiposityFatty LiverAlcohol Use Disorder
Insel Gruppe AG, University Hospital Bern 64
Large-scale testing (Phase 3)UnknownNCT05942547
What this trial is testing

The Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis.

Who this might be right for
Non Alcoholic Steatohepatitis
Tanta University 48
Not applicableUnknownNCT06535048
What this trial is testing

Impact of Fatty Liver on Hepatitis B Therapy

Who this might be right for
Fatty Liver DiseaseChronic Hepatitis BAntiviral Treatment
Tianjin Second People's Hospital 500
Not applicableUnknownNCT04369521
What this trial is testing

Evaluation of the Effects of a Low Free Sugar Diet in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
National Nutrition and Food Technology Institute 50
Not applicableLooking for participantsNCT05597709
What this trial is testing

Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China

Who this might be right for
Type 2 Diabetes Mellitus in RemissionMetabolic Associated Fatty Liver Disease
Wuxi Hisky Medical Technology Co Ltd 2,900
Post-approval studies (Phase 4)Study completedNCT07363707
What this trial is testing

A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.

Who this might be right for
NAFLD (Nonalcoholic Fatty Liver Disease)
Beni-Suef University 108
Next Page